Scientists Are Globally Testing a New Drug to Prevent Dementia Before Symptoms Begin
Over the last few years, scientists have made significant progress in developing innovative treatments for Alzheimer’s disease. In 2022, for the first time, a trial of a drug called lecanemab showed that the progression of Alzheimer’s can be slowed by medication, while another drug, donanemab, produced similarly promising results.





































































